首页> 美国卫生研究院文献>The Application of Clinical Genetics >The genetics of breast cancer: risk factors for disease
【2h】

The genetics of breast cancer: risk factors for disease

机译:乳腺癌的遗传学:疾病的危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The genetic factors known to be involved in breast cancer risk comprise about 30 genes. These include the high-penetrance early-onset breast cancer genes, BRCA1 and BRCA2, a number of rare cancer syndrome genes, and rare genes with more moderate penetrance. A larger group of common variants has more recently been identified through genome-wide association studies. Quite a number of these common variants are mapped to genomic regions without being firmly associated with specific genes. It is thought that most of these variants have gene regulatory functions, but their precise roles in disease susceptibility are not well understood. Common variants account for only a small percentage of the risk of disease because they have low penetrance. Collectively, the breast cancer genes identified to date contribute only ~30% of the familial risk. Therefore, there is much interest in accounting for the missing heritability, and possible sources include loss of information through ignoring phenotype heterogeneity (disease subtypes have genetic differences), gene–gene and gene–environment interaction, and rarer forms of variation. Identification of these rarer variations in coding regions is now feasible and cost effective through exome sequencing, which has already identified high-penetrance variants for some rare diseases. Targeting more ‘extreme’ breast cancer phenotypes, particularly cases with early-onset disease, a strong family history (not accounted for by BRCA mutations), and with specific tumor subtypes, provides a route to progress using next-generation sequencing methods.
机译:已知与乳腺癌风险有关的遗传因素包括约30个基因。这些基因包括高渗透率的早发乳腺癌基因,BRCA1和BRCA2,许多罕见的癌症综合征基因以及渗透率中等的罕见基因。最近,通过全基因组关联研究确定了一大类常见变异。这些常见变体中有许多都映射到基因组区域,而没有与特定基因牢固关联。据认为,大多数这些变体具有基因调节功能,但是它们在疾病易感性中的确切作用尚不清楚。常见变异体的渗透率低,因此仅占疾病风险的一小部分。总体而言,迄今为止确定的乳腺癌基因仅占家族风险的约30%。因此,人们对解决遗漏的遗传性问题非常感兴趣,可能的来源包括通过忽略表型异质性(疾病亚型具有遗传差异),基因-基因和基因-环境相互作用以及稀有形式的变异而导致信息丢失。现在,通过外显子组测序鉴定编码区中这些罕见的变异是可行且具有成本效益的,外显子测序已为某些罕见疾病鉴定了高渗透性变异。针对更多的“极端”乳腺癌表型,尤其是那些患有早发性疾病,家族史(不包括BRCA突变的患者)和特定肿瘤亚型的病例,可以为下一代测序方法的发展提供途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号